DK1267922T3 - Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri - Google Patents

Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri

Info

Publication number: DK1267922T3
Authority: DK; Denmark
Prior art keywords: diphtheria; pneumococci; vaccine against; polysaccharide conjugates; against tetanus
Prior art date: 2000-03-17

Application number

DK01917183T

Other languages

Danish (da)

English (en)

Inventor

Dominique Schulz

Original Assignee

Sanofi Pasteur

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-17

Filing date

2001-03-19

Publication date

2005-10-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8848189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1267922(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-03-19 Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur

2005-10-17 Application granted granted Critical

2005-10-17 Publication of DK1267922T3 publication Critical patent/DK1267922T3/da

Links

206010043376 Tetanus Diseases 0.000 title abstract 3
206010013023 diphtheria Diseases 0.000 title abstract 3
150000004676 glycans Chemical class 0.000 title abstract 3
229920001282 polysaccharide Polymers 0.000 title abstract 3
239000005017 polysaccharide Substances 0.000 title abstract 3
229960005486 vaccine Drugs 0.000 title abstract 3
241000193449 Clostridium tetani Species 0.000 abstract 2
241000193998 Streptococcus pneumoniae Species 0.000 abstract 2
229940031000 streptococcus pneumoniae Drugs 0.000 abstract 2
229960003983 diphtheria toxoid Drugs 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229960000814 tetanus toxoid Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Mycology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK01917183T 2000-03-17 2001-03-19 Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri DK1267922T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0003407A FR2806304B1 (fr)	2000-03-17	2000-03-17	Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
PCT/FR2001/000820 WO2001068128A1 (fr)	2000-03-17	2001-03-19	Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie

Publications (1)

Publication Number	Publication Date
DK1267922T3 true DK1267922T3 (da)	2005-10-17

Family

ID=8848189

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01917183T DK1267922T3 (da)	2000-03-17	2001-03-19	Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri

Country Status (11)

Country	Link
US (1)	US20030099672A1 (de)
EP (1)	EP1267922B1 (de)
AT (1)	ATE297758T1 (de)
AU (1)	AU2001244275A1 (de)
CA (1)	CA2402807A1 (de)
DE (1)	DE60111507T2 (de)
DK (1)	DK1267922T3 (de)
ES (1)	ES2240432T3 (de)
FR (1)	FR2806304B1 (de)
PT (1)	PT1267922E (de)
WO (1)	WO2001068128A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU227893B1 (en) *	2000-06-29	2012-05-29	Glaxosmithkline Biolog Sa	Vaccine compositions
US8398983B2 (en)	2005-06-27	2013-03-19	Glaxosmithkline Biologicals, S.A.	Immunogenic composition
PL1973564T3 (pl)	2005-12-22	2017-04-28	Glaxosmithkline Biologicals S.A.	Szczepionki zawierające koniugaty polisacharydu otoczkowego streptococcus pneumoniae
GB0607088D0 (en) *	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
SI2167121T1 (sl)	2007-06-26	2015-12-31	Glaxosmithkline Biologicals S.A.	Cepivo, ki obsega kapsularne polisaharidne konjugate Streptococcusa pneumoniae
GB2495341B (en) *	2011-11-11	2013-09-18	Novartis Ag	Fermentation methods and their products
KR102057217B1 (ko)	2012-06-20	2020-01-22	에스케이바이오사이언스 주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
ITMI20121597A1 (it) *	2012-09-25	2014-03-26	Beta Pharma S A	Coniugato tra frammento di parete cellulare batterica ed un veicolo mucopolisaccaridico e suoi usi in ambito medico
KR20140075196A (ko)	2012-12-11	2014-06-19	에스케이케미칼주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
EP2934574A1 (de)	2012-12-18	2015-10-28	GlaxoSmithKline Biologicals SA	Konjugate zum schutz gegen diphterie und/oder tetanus
US9815886B2 (en)	2014-10-28	2017-11-14	Adma Biologics, Inc.	Compositions and methods for the treatment of immunodeficiency
JP7001686B2 (ja)	2016-08-05	2022-02-04	サノフィパスツールインコーポレイティッド	多価肺炎球菌多糖体－タンパク質コンジュゲート組成物
KR102437120B1 (ko) *	2016-08-05	2022-08-25	사노피 파스퇴르 인코포레이티드	다가 폐렴구균 다당류-단백질 접합체 조성물
US10259865B2 (en)	2017-03-15	2019-04-16	Adma Biologics, Inc.	Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US10729763B2 (en)	2017-06-10	2020-08-04	Inventprise, Llc	Mixtures of polysaccharide-protein pegylated compounds
MX2019014829A (es)	2017-06-10	2020-08-17	Inventprise Llc	Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas.
KR20230008923A (ko) *	2018-02-05	2023-01-16	사노피 파스퇴르 인코포레이티드	다가 폐렴구균성 다당류-단백질 접합체 조성물
AU2019215212B2 (en)	2018-02-05	2025-05-15	Sk Bioscience Co., Ltd.	Multivalent pneumococcal polysaccharide-protein conjugate composition
JP2021522213A (ja)	2018-04-18	2021-08-30	エスケーバイオサイエンスカンパニーリミテッド	ストレプトコッカス・ニューモニエ莢膜多糖類及びその免疫原性接合体
BR112022001654A2 (pt) *	2019-07-31	2022-07-12	Sanofi Pasteur Inc	Composições conjugadas de proteinas de polissacarídeos pneumocócicos multivalentes e métodos de utilização dos mesmos
WO2022035816A1 (en)	2020-08-10	2022-02-17	Inventprise, Llc	Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
CN113607939B (zh) *	2021-08-05	2024-10-22	艾美探索者生命科学研发有限公司	肺炎球菌多糖结合疫苗各型结合原液吸附率测定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4619828A (en) *	1982-07-06	1986-10-28	Connaught Laboratories, Inc.	Polysaccharide exotoxoid conjugate vaccines
US5204098A (en) *	1988-02-16	1993-04-20	The United States Of America As Represented By The Department Of Health And Human Services	Polysaccharide-protein conjugates
US5153312A (en) *	1990-09-28	1992-10-06	American Cyanamid Company	Oligosaccharide conjugate vaccines
FR2682388B1 (fr) *	1991-10-10	1995-06-09	Pasteur Merieux Serums Vacc	Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
TR199701547T1 (xx) *	1995-06-07	1998-03-21	Smithkline Beecham Biologicals S.A.	Polisakarit antijen protein e�leni�i i�eren a��.
FR2763244B1 (fr) *	1997-05-14	2003-08-01	Pasteur Merieux Serums Vacc	Composition vaccinale multivalente a porteur mixte
WO1999039739A1 (en) *	1998-02-05	1999-08-12	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media

2000
- 2000-03-17 FR FR0003407A patent/FR2806304B1/fr not_active Expired - Fee Related
2001
- 2001-03-19 DE DE60111507T patent/DE60111507T2/de not_active Expired - Lifetime
- 2001-03-19 ES ES01917183T patent/ES2240432T3/es not_active Expired - Lifetime
- 2001-03-19 AU AU2001244275A patent/AU2001244275A1/en not_active Abandoned
- 2001-03-19 US US10/221,978 patent/US20030099672A1/en not_active Abandoned
- 2001-03-19 AT AT01917183T patent/ATE297758T1/de active
- 2001-03-19 WO PCT/FR2001/000820 patent/WO2001068128A1/fr not_active Ceased
- 2001-03-19 PT PT01917183T patent/PT1267922E/pt unknown
- 2001-03-19 EP EP01917183A patent/EP1267922B1/de not_active Revoked
- 2001-03-19 CA CA002402807A patent/CA2402807A1/en not_active Abandoned
- 2001-03-19 DK DK01917183T patent/DK1267922T3/da active

Also Published As

Publication number	Publication date
WO2001068128A1 (fr)	2001-09-20
DE60111507T2 (de)	2006-05-11
FR2806304A1 (fr)	2001-09-21
AU2001244275A1 (en)	2001-09-24
FR2806304B1 (fr)	2002-05-10
DE60111507D1 (de)	2005-07-21
ATE297758T1 (de)	2005-07-15
CA2402807A1 (en)	2001-09-20
US20030099672A1 (en)	2003-05-29
EP1267922A1 (de)	2003-01-02
EP1267922B1 (de)	2005-06-15
ES2240432T3 (es)	2005-10-16
PT1267922E (pt)	2005-09-30

Publication	Publication Date	Title
DK1267922T3 (da)	2005-10-17	Polysaccharidkonjugater af pneumokokker til anvendelse som vaccine mod tetanus og difteri
EA200901578A1 (ru)	2010-08-30	Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
MY150719A (en)	2014-02-28	Pneumococcal polysaccharide conjugate vaccine
HUP0301413A1 (hu)	2003-08-28	Vakcinakészítmények
MY125387A (en)	2006-07-31	Vaccine
PE20161095A1 (es)	2016-10-26	Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos
WO2002091998A3 (en)	2003-02-27	Novel meningitis conjugate vaccine
EA200801935A1 (ru)	2009-04-28	Конъюгатные вакцины
MY145150A (en)	2011-12-30	Multivalent pneumococcal polysaccharide-protein conjugate composition
GEAP202316334A (en)	2023-11-10	Nanoemulsion adjuvant composition for pneumococcal conjugate vaccines
UA99703C2 (en)	2012-09-25	Use of streptococcus pneumoniae immunogenic composition
CO5241278A1 (es)	2003-01-31	Vacuna